Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trialEileen M. Boyle, Xavier Leleu, Marie‐Odile Petillon et al.|British Journal of Haematology|2019Cited by 23